MARTIN WAYNE DILLOW MD NPI 1073730867

NPI Details

Martin Wayne Dillow, MD is a family medicine in Chanute, KS with 21 years of experience. The provider is family Medicine is the medical specialty which is concerned with the total health care of the individual and the family. It is the specialty in breadth which integrates the biological, clinical, and behavioral sciences. The scope of family medicine is not limited by age, sex, organ system, or disease entity. Martin Wayne Dillow, MD NPI is 1073730867. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF KANSAS SCHOOL OF MED (KC/WICH/SAL)
Graduation Year:2005

The provider's business location address is:

505 S PLUMMER AVE
CHANUTE, KS
ZIP 66720-950
Phone: (620) 431-2500
Fax: (620) 431-4418

The NPI 1073730867 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Hemoglobin a1c level (HCPCS:83036)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
• Urine microalbumin (protein) analysis (HCPCS:82044)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Influenza vaccine, quadrivalent derived from recombinant dna (HCPCS:90682)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Blood test, clotting time (HCPCS:85610)
• Magnesium level (HCPCS:83735)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Prostate cancer screening; prostate specific antigen test (psa) (HCPCS:G0103)
• X-ray of chest, 2 views (HCPCS:71046)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Follow-up nursing facility visit per day, typically 15 minutes (HCPCS:99308)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Hospital discharge day management, 30 minutes or less (HCPCS:99238)
• X-ray of abdomen, 2 views (HCPCS:74019)
• Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
• Vitamin d-3 level (HCPCS:82306)
• Administration of pneumococcal vaccine (HCPCS:G0009)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Transitional care management services for problem of moderate complexity (HCPCS:99495)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Detection test by immunoassay with direct visual observation for influenza virus (HCPCS:87804)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Natriuretic peptide (heart and blood vessel protein) level (HCPCS:83880)
• Pneumococcal vaccine, 23-valent (HCPCS:90732)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment (HCPCS:77085)
• Destruction of precancer skin growth, 1 growth (HCPCS:17000)
• Initial hospital observation care per day, typically 50 minutes (HCPCS:99219)
• Uric acid level, blood (HCPCS:84550)
• Destruction of skin growth, 1-14 growths (HCPCS:17110)
• Digoxin level, total (HCPCS:80162)
• Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment (HCPCS:G0402)
• Melanoma (skin cancer) excision (HCPCS:NAN03)

The enumeration date for this NPI number is 4/20/2007 and was last updated on 8/3/2011.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.